The combined company will focus on advancing Dianthus' pipeline of next-generation complement inhibitors, including DNTH103, currently in Phase 1 trial. Upon completion of the merger, the combined ...

U.S.-based paint supplier company Axalta has announced Royal Magenta as the Global Automotive Color of the Year 2022. The announcement marks Axalta’s eighth Global Automotive Color of the Year. Last ...

Magenta Medical wants to disrupt the mechanical circulatory support (MCS) market with the Elevate Percutaneous Left Ventricular Assist Device (pLVAD). The Kadima, Israel-based company is developing ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to ...

Magenta Therapeutics’ MGTA-117 blood cancer clinical trial has gone from bad to worse. Weeks after Magenta dropped down a dose level in response to serious adverse events (SAEs), a patient has died ...

Magenta Medical – who made waves in the medtech space when it unveiled the world’s smallest heart pump – has raised $105m to support clinical trials in the US evaluating the technology. The financing ...

Magenta Therapeutics has stopped dosing a group of patients after a serious adverse event was reported in a phase 1/2 trial for the biotech’s leukemia med. MGTA-117 is being tested in the split-phase ...

Forbes contributors publish independent expert analyses and insights. Aly Walansky is a NY-based journalist who covers cocktails and dining. This article is more than 3 years old. Pantone recently ...

With premium viewing areas and complimentary amenities at major concerts, sporting events and music festivals, T-Mobile seeks ...

Magenta Therapeutics Inc (NASDAQ: MGTA) and privately-held Dianthus Therapeutics Inc have announced to merge in an all-stock transaction. The combined company will focus on advancing Dianthus' ...